ATTs BlueCollar Hiring Challenge Signals a Shift in the AIDriven Economy EEOC May End DecadesOld Demographic Data Collection Requirement Reshaping Workplace Discrimination Enforcement UK Households Face Energy Bill Anxiety as Price Cap Forecast to Rise 209 to 1900 South KoreaNetherlands Semiconductor Partnership Extends Beyond ASML Collaboration Balanced GrowthValue Strategy Gains Attention for MemoryChip Rally Play Wall Street Ends Higher as Healthcare Technology Lead Communication Services Lags ELVN Q1 2026 Earnings NarrowerthanExpected Loss as PreRevenue Biotech Advances Pipeline SCCO Q1 2026 Earnings Strong EPS Beat Signals Operational Resilience HCAT Q1 2026 Earnings Earnings Beat Sentiment but Stock Slips ACIW Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher Murphy USA Inc MUSA Q1 2026 Earnings Earnings Surge Past Estimates Stock Slips Marginally REVB Q1 2026 Earnings Significant EPS Miss Amid EarlyStage Development Amplitude Inc AMPL Finds Support Near 637 Eyes Resistance at 704 After 276 Gain Willow Lane Acquisition Corp II Unit WLIIU Holds Steady at 1018 as Market Awaits Catalyst Inspire Medical Systems INSP Dips 2 as Stock Tests Key Support Levels Murano Global Investments Warrants MRNOW Slips 625 Trading at Support Near 003 Life360 Inc LIF Gains 211 as Trading Activity Picks Up Near Key Resistance Helmerich Payne HP Slips 1 as Energy Sector Faces Headwinds Palvella Therapeutics PVLA Shows Resilience with Slight Gain Testing Key Resistance Champion Homes SKY Rises 11 Approaching Key Resistance FST Corp KBSX Slips 22 as Support at 128 Comes Into Focus Innospec Inc IOSP Holds Steady Near 82 Amid Low Volatility Jackson Financial JXN Pulls Back After Recent Rally Testing Support Near 100 Rise in Solar Panel Purchases Driven by Energy Cost Savings Company Director Invests in 2000 Panels IBRX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress Vendome Acquisition Corp I VNME Holding Steady at 1017 Amid SPAC Market Stability PVH Q1 2026 Earnings EPS Surges Past Estimates Amidst Strong Brand Performance RLI Q1 2026 Earnings EPS Beats by Nearly 5 as Underwriting Disciplines Deliver Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns STRK Q1 2026 Earnings Massive EPS Miss as Preferred Stock Posts Steep Loss REXR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency CTOR Q1 2026 Earnings EPS Falls Far Below Estimates as PreRevenue Company Continues RD Investment HCA Q1 2026 Earnings EPS Misses Estimates Amid Narrow Surprise and Flat Stock Reaction